{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:56:27Z","timestamp":1772715387906,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T00:00:00Z","timestamp":1548720000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12887-019-1402-1","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T08:04:43Z","timestamp":1548749083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Predictors of treatment failure, time to switch and reasons for switching to second line antiretroviral therapy in HIV infected children receiving first line anti-retroviral therapy at a Tertiary Care Hospital in Ethiopia"],"prefix":"10.1186","volume":"19","author":[{"given":"Gelila Solomon","family":"Haile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3825-2863","authenticated-orcid":false,"given":"Alemseged Beyene","family":"Berha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,29]]},"reference":[{"key":"1402_CR1","unstructured":"UNAIDS: New global push to close paediatric HIV treatment gap launched. In.; 20 July 2016."},{"key":"1402_CR2","unstructured":"EPHI: HIV Related Estimates and Projections for Ethiopia. In. Addis Ababa , Ethiopia: Ethiopian Public Health Institute; March, 2017."},{"issue":"9534","key":"1402_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(06)69158-7","volume":"368","author":"CF Gilks","year":"2006","unstructured":"Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, Sutherland D, Vitoria M, Guerma T, De Cock K. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet. 2006;368(9534):505\u201310.","journal-title":"Lancet"},{"issue":"2","key":"1402_CR4","doi-asserted-by":"publisher","first-page":"e87872","DOI":"10.1371\/journal.pone.0087872","volume":"9","author":"JS Montaner","year":"2014","unstructured":"Montaner JS, Lima VD, Harrigan PR, Louren\u00e7o L, Yip B, Nosyk B, Wood E, Kerr T, Shannon K, Moore D. Expansion of HAART coverage is associated with sustained decreases in HIV\/AIDS morbidity, mortality and HIV transmission: the \u201cHIV Treatment as Prevention\u201d experience in a Canadian setting. PloS one. 2014;9(2):e87872.","journal-title":"PloS one"},{"issue":"5","key":"1402_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/15284336.2016.1201300","volume":"17","author":"I Singini","year":"2016","unstructured":"Singini I, Campbell TB, Smeaton LM, Kumarasamy N, La Rosa A, Taejareonkul S, Safren SA, Flanigan TP, Hakim JG, Hughes MD. Predictors of late virologic failure after initial successful suppression of HIV replication on efavirenz-based antiretroviral therapy. HIV Clin Trials. 2016;17(5):173\u201380.","journal-title":"HIV Clin Trials"},{"key":"1402_CR6","volume-title":"HIV\/AIDS Glossary :Treatment Failure","author":"AIDSinfo","year":"2018","unstructured":"AIDSinfo. In: Services USDoHaH, editor. HIV\/AIDS Glossary :Treatment Failure; 2018."},{"issue":"9","key":"1402_CR7","first-page":"973","volume":"38","author":"WHO","year":"2017","unstructured":"WHO. World Health Organization urges action against HIV drug resistance threat. Saudi Med J. 2017;38(9):973\u20134.","journal-title":"Saudi Med J"},{"issue":"5","key":"1402_CR8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1473-3099(15)00536-8","volume":"16","author":"Group TS","year":"2016","unstructured":"Group TS. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect Dis. 2016;16(5):565\u201375.","journal-title":"Lancet Infect Dis"},{"issue":"18","key":"1402_CR9","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1056\/NEJMsb035366","volume":"348","author":"SJ Reynolds","year":"2003","unstructured":"Reynolds SJ, Bartlett JG, Quinn TC, Beyrer C, Bollinger RC. Antiretroviral therapy where resources are limited. N Engl J Med. 2003;348(18):1806\u20139.","journal-title":"N Engl J Med"},{"issue":"5","key":"1402_CR10","doi-asserted-by":"publisher","first-page":"e98152","DOI":"10.1371\/journal.pone.0098152","volume":"9","author":"CT Solem","year":"2014","unstructured":"Solem CT, Snedecor SJ, Khachatryan A, Nedrow K, Tawadrous M, Chambers R, Haider S, Simpson K. Cost of treatment in a US commercially insured, HIV-1\u2013Infected POPULATION. PloS one. 2014;9(5):e98152.","journal-title":"PloS one"},{"key":"1402_CR11","unstructured":"Campaign MA: Untangling the Web of Antiretroviral Price Reductions 18th Edition. In. CH-1211 Geneva 21, Switzerland: M\u00e9decins Sans Fronti\u00e8res; 2016."},{"key":"1402_CR12","unstructured":"Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA. Division of HIV\/AIDS Prevention strategic plan 2017-2020. MMWR Morb Mortal Wkly Rep. 63:4."},{"issue":"9290","key":"1402_CR13","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/S0140-6736(01)06413-3","volume":"358","author":"J Fellay","year":"2001","unstructured":"Fellay J, Ledergerber B, Bernasconi E, Furrer H, Battegay M, Hirschel B, Vernazza P, Francioli P, Greub G, Flepp M. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet. 2001;358(9290):1322\u20137.","journal-title":"Lancet"},{"issue":"9","key":"1402_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"Group ISS","year":"2015","unstructured":"Group ISS. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795\u2013807.","journal-title":"N Engl J Med"},{"issue":"1","key":"1402_CR15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/INF.0000000000001719","volume":"37","author":"A Seth","year":"2018","unstructured":"Seth A, Malhotra RK, Gupta R, Chandra J, Kumar P, Singh S, Sharma G. Effect of Antiretroviral Therapy on Growth Parameters of Children With HIV Infection. Pediatr Infect Dis J. 2018;37(1):85\u20139.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"1402_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4314\/ejhs.v27i1.1S","volume":"27","author":"G Barnabas","year":"2017","unstructured":"Barnabas G, Sibhatu MK, Berhane Y. Antiretroviral therapy program in Ethiopia benefits from virology treatment monitoring. Ethiopian J Health Sci. 2017;27(1):1\u20132.","journal-title":"Ethiopian J Health Sci"},{"issue":"14","key":"1402_CR17","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1097\/QAD.0000000000000349","volume":"28","author":"ML Petersen","year":"2014","unstructured":"Petersen ML, Tran L, Geng EH, Reynolds SJ, Kambugu A, Wood R, Bangsberg DR, Yiannoutsos CT, Deeks SG, Martin JN. Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa. AIDS (London, England). 2014;28(14):2097.","journal-title":"AIDS (London, England)"},{"issue":"8","key":"1402_CR18","doi-asserted-by":"publisher","first-page":"e0161469","DOI":"10.1371\/journal.pone.0161469","volume":"11","author":"JK Rohr","year":"2016","unstructured":"Rohr JK, Ive P, Horsburgh CR, Berhanu R, Shearer K, Maskew M, Long L, Sanne I, Bassett J, Ebrahim O. Marginal structural models to assess delays in second-line HIV treatment initiation in South Africa. PloS one. 2016;11(8):e0161469.","journal-title":"PloS one"},{"key":"1402_CR19","doi-asserted-by":"crossref","unstructured":"Ramadhani HO, Bartlett JA, Thielman NM, Pence BW, Kimani SM, Maro VP, Mwako MS, Masaki LJ, Mmbando CE, Minja MG. The effect of switching to second-line antiretroviral therapy on the risk of opportunistic infections among patients infected with human immunodeficiency virus in northern Tanzania. Open Forum Infect Dis. 2016;3(1).","DOI":"10.1093\/ofid\/ofw018"},{"key":"1402_CR20","volume-title":"Antiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach-2010 revision","author":"WHO","year":"2010","unstructured":"WHO. Antiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach-2010 revision. Austria: World Health Organization; 2010."},{"issue":"11","key":"1402_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5897\/IJMMS2015.1164","volume":"8","author":"A Zeleke","year":"2016","unstructured":"Zeleke A. Prevalence of antiretroviral treatment failure and associated factors in HIV infected children on antiretroviral therapy at Gondar University Hospital, retrospective cohort study. Int J Med Med Sci. 2016;8(11):125\u201332.","journal-title":"Int J Med Med Sci"},{"issue":"1","key":"1402_CR22","doi-asserted-by":"publisher","first-page":"e00296","DOI":"10.1002\/prp2.296","volume":"5","author":"S Yassin","year":"2017","unstructured":"Yassin S, Gebretekle GB. Magnitude and predictors of antiretroviral treatment failure among HIV\u2010infected children in Fiche and Kuyu hospitals, Oromia region, Ethiopia: a retrospective cohort study. Pharmacol Res Perspect. 2017;5(1):e00296.","journal-title":"Pharmacol Res Perspect"},{"issue":"1","key":"1402_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/1471-2334-12-197","volume":"12","author":"T Bacha","year":"2012","unstructured":"Bacha T, Tilahun B, Worku A. Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapy. BMC Infect Dis. 2012;12(1):197.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"1402_CR24","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/INF.0000000000001672","volume":"36","author":"AEN Nlend","year":"2017","unstructured":"Nlend AEN, Motaze AN, Ndiang ST, Fokam J. Predictors of Virologic Failure on First-line Antiretroviral Therapy Among Children in a Referral Pediatric Center in Cameroon. Pediatr Infect Dis J. 2017;36(11):1067\u201372.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"1402_CR25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3851\/IMP2562","volume":"18","author":"A Zoufaly","year":"2013","unstructured":"Zoufaly A, Fillekes Q, Hammerl R, Nassimi N, Jochum J, Drexler JF, Awasom CN, Sunjoh F, Burchard GD, Burger DM. Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study. Antivir Ther. 2013;18(5):681\u201390.","journal-title":"Antivir Ther"},{"issue":"10","key":"1402_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0000000000006282","volume":"96","author":"CD Mossoro-Kpinde","year":"2017","unstructured":"Mossoro-Kpinde CD, Gody J-C, Bouassa R-SM, Mbitikon O, Jenabian M-A, Robin L, Matta M, Zeitouni K, Longo JDD, Costiniuk C. High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-sectional study. Medicine. 2017;96(10):1\u201315.","journal-title":"Medicine"},{"key":"1402_CR27","volume-title":"WHO Definitions of Clinical, Immunological and Virological Failure for the Decision to Switch ART Regimens","author":"WHO","year":"2013","unstructured":"WHO: WHO Definitions of Clinical, Immunological and Virological Failure for the Decision to Switch ART Regimens. 2013."},{"issue":"28","key":"1402_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0000000000003985","volume":"95","author":"ND Labhardt","year":"2016","unstructured":"Labhardt ND, Bader J, Lejone TI, Ringera I, Hobbins MA, Fritz C, Ehmer J, Cerutti B, Puga D, Klimkait T. Should viral load thresholds be lowered?: revisiting the WHO definition for virologic failure in patients on antiretroviral therapy in resource-limited settings. Medicine. 2016;95(28):1\u20137.","journal-title":"Medicine"},{"issue":"1","key":"1402_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12879-018-2979-y","volume":"18","author":"A Amstutz","year":"2018","unstructured":"Amstutz A, Nsakala BL, Vanobberghen F, Muhairwe J, Glass TR, Achieng B, Sepeka M, Tlali K, Sao L, Thin K. SESOTHO trial (\u201cSwitch Either near Suppression Or THOusand\u201d)\u2013switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies\/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa. BMC Infect Dis. 2018;18(1):76.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1402_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/jpids\/piu032","volume":"4","author":"P Costenaro","year":"2014","unstructured":"Costenaro P, Penazzato M, Lundin R, Rossi G, Massavon W, Patel D, Nabachwa S, Franceschetto G, Morelli E, Bilardi D. Predictors of treatment failure in HIV-positive children receiving combination antiretroviral therapy: cohort data from Mozambique and Uganda. J Pediatr Infect Dis Soc. 2014;4(1):39\u201348.","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"2","key":"1402_CR31","first-page":"75","volume":"19","author":"N Workneh","year":"2009","unstructured":"Workneh N, Girma T, Woldie M. Immunologic and clinical outcomes of children on HAART: a Retrospective cohort analysis at Jimma University specialized hospital. Ethiopian J Health Sci. 2009;19(2):75\u201382.","journal-title":"Ethiopian J Health Sci"},{"issue":"4","key":"1402_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/09540121.2013.841829","volume":"26","author":"S Sivapalasingam","year":"2014","unstructured":"Sivapalasingam S, Mendillo M, Ahmed A, Mwamzuka M, Said S, Marshed F, Luhar Abdulaziz F, Fajans M, Holzman R. The importance of caregivers in the outcome of pediatric HIV management, Mombasa, Kenya. AIDS Care. 2014;26(4):425\u201333.","journal-title":"AIDS Care"},{"key":"1402_CR33","unstructured":"Bloom B, Cohen RA, Freeman G: Summary health statistics for US children; National health interview survey, 2011. 2012."},{"issue":"1","key":"1402_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/17441692.2011.574147","volume":"7","author":"C Chuong","year":"2012","unstructured":"Chuong C, Operario D. Challenging household dynamics: Impact of orphanhood, parental absence, and children's living arrangements on education in South Africa. Glob Public Health. 2012;7(1):42\u201357.","journal-title":"Glob Public Health"},{"issue":"4","key":"1402_CR35","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1179\/0024363914Z.00000000087","volume":"81","author":"J Anderson","year":"2014","unstructured":"Anderson J. The impact of family structure on the health of children: Effects of divorce. Linacre Q. 2014;81(4):378\u201387.","journal-title":"Linacre Q"},{"issue":"6","key":"1402_CR36","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/cch.12387","volume":"42","author":"L Sherr","year":"2016","unstructured":"Sherr L, Skeen S, Hensels I, Tomlinson M, Macedo A. The effects of caregiver and household HIV on child development: a community\u2010based longitudinal study of young children. Child Care Health Dev. 2016;42(6):890\u20139.","journal-title":"Child Care Health Dev"},{"issue":"1","key":"1402_CR37","first-page":"32","volume":"10","author":"S Sovran","year":"2013","unstructured":"Sovran S. Understanding culture and HIV\/AIDS in sub-Saharan Africa. SAHARA. 2013;10(1):32\u201341.","journal-title":"SAHARA"},{"issue":"4","key":"1402_CR38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/09540120050123783","volume":"12","author":"X Gao","year":"2000","unstructured":"Gao X, Nau D, Rosenbluth S, Scott V, Woodward C. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care. 2000;12(4):387\u201398.","journal-title":"AIDS Care"},{"issue":"6","key":"1402_CR39","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/INF.0b013e318194eea6","volume":"28","author":"T Puthanakit","year":"2009","unstructured":"Puthanakit T, Kerr SJ, Ananworanich J, Bunupuradah T, Boonrak P, Sirisanthana V. Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy. Pediatr Infect Dis J. 2009;28(6):488\u201392.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"1402_CR40","doi-asserted-by":"publisher","first-page":"e0195514","DOI":"10.1371\/journal.pone.0195514","volume":"13","author":"L Kuhn","year":"2018","unstructured":"Kuhn L, Paximadis M, Dias BDC, Loubser S, Strehlau R, Patel F, Shiau S, Coovadia A, Abrams EJ, Tiemessen CT. Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children. PloS one. 2018;13(4):e0195514.","journal-title":"PloS one"},{"issue":"12","key":"1402_CR41","doi-asserted-by":"publisher","first-page":"e82724","DOI":"10.1371\/journal.pone.0082724","volume":"8","author":"Y Madec","year":"2013","unstructured":"Madec Y, Leroy S, Rey-Cuille M-A, Huber F, Calmy A. Persistent difficulties in switching to second-line ART in sub-Saharan Africa\u2014a systematic review and meta-analysis. PloS one. 2013;8(12):e82724.","journal-title":"PloS one"},{"issue":"1","key":"1402_CR42","first-page":"1","volume":"18","author":"D Narainsamy","year":"2017","unstructured":"Narainsamy D, Mahomed S. Delays in switching patients onto second-line antiretroviral treatment at a public hospital in eThekwini, KwaZulu-Natal. Southern Afr J HIV Med. 2017;18(1):1\u20135.","journal-title":"Southern Afr J HIV Med"},{"issue":"4","key":"1402_CR43","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/QAI.0b013e3182557785","volume":"60","author":"MP Fox","year":"2012","unstructured":"Fox MP, Van Cutsem G, Giddy J, Maskew M, Keiser O, Prozesky H, Wood R, Hern\u00e1n MA, Sterne JA, Egger M. Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa. J Acquir Immune Defic Syndr (1999). 2012;60(4):428.","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"issue":"6","key":"1402_CR44","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3851\/IMP1819","volume":"16","author":"JH Levison","year":"2011","unstructured":"Levison JH, Orrell C, Losina E, Lu Z, Freedberg KA, Wood R. Early outcomes and the virologic impact of delayed treatment switching on second-line therapy in an antiretroviral roll-out program in South Africa. Antivir Ther. 2011;16(6):853.","journal-title":"Antivir Ther"},{"issue":"14","key":"1402_CR45","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1097\/QAD.0b013e32832e05b2","volume":"23","author":"O Keiser","year":"2009","unstructured":"Keiser O, Tweya H, Boulle A, Braitstein P, Schechter M, Brinkhof MW, Dabis F, Tuboi S, Sprinz E, Pujades-Rodriguez M. Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring. AIDS (London, England). 2009;23(14):1867.","journal-title":"AIDS (London, England)"},{"key":"1402_CR46","doi-asserted-by":"crossref","unstructured":"Narainsamy D, Mahomed S. Delays in switching patients onto second-line antiretroviral treatment at a public hospital in eThekwini, KwaZulu-Natal. South Afr J HIV Med. 2017;18(1).","DOI":"10.4102\/sajhivmed.v18i1.696"},{"key":"1402_CR47","volume-title":"National guidelines for comprehensive HIV prevention, care and treatment","author":"N Frehiwot","year":"2014","unstructured":"Frehiwot N, Mizan K, Seble M, Fethia K, Tekalign M, Zelalem T. National guidelines for comprehensive HIV prevention, care and treatment. Addis Ababa: Ministry of Health; 2014."},{"key":"1402_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1874613601812010011","volume":"12","author":"YS Low","year":"2018","unstructured":"Low YS, Islahudin F, Razali KAM, Adnan S. Modification of Initial Highly Active Antiretroviral Therapy (HAART) Regimen in Paediatric HIV Patients. Open AIDS J. 2018;12:11.","journal-title":"Open AIDS J"},{"issue":"1","key":"1402_CR49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4172\/jaa.1000040","volume":"4","author":"S Takuva","year":"2012","unstructured":"Takuva S, Louwagie G, Zuma K, Okello V. Durability of first line antiretroviral therapy: reasons and predictive factors for modifications in a Swaziland cohort. J Antivir Antiretrovir. 2012;4(1):14\u201320.","journal-title":"J Antivir Antiretrovir"},{"key":"1402_CR50","volume-title":"Prevention of Mother to Child Transmission of HIV (PMTCT) Case Team","author":"EMoH","year":"2013","unstructured":"EMoH. Prevention of Mother to Child Transmission of HIV (PMTCT) Case Team. Addis Ababa, Ethiopia: Ethiopian Ministry of Health; 2013."}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1402-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1402-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1402-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T20:36:07Z","timestamp":1580243767000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1402-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,29]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1402"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1402-1","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,29]]},"assertion":[{"value":"17 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was done after the letter of ethical approval with a reference number of ERB\/SOP\/18\/10\/2018 was obtained from ethical review roard of School of Pharmacy, Addis Ababa University. All of the children at the HIV clinic who had been started on first line ART drugs based on the Ethiopia national guideline were included. Waiver of consent letter for this retrospective chart review was obtained from the Department of Pediatric and Child Health of TASH with a letter reference number: PD\/SOM\/206\/10 to review patients\u2019 charts for data collection. Privacy and confidentiality was strictly maintained throughout the whole process.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"37"}}